Focus is on patients with presumed autoimmune mediated diseases, whose treatment with disease modifying agents or chemotherapeutic agents, or the disease in itself, render the sufferer immunodeficient.

Patients of this kind are seen in rheumatology, neurology, gastroenterology and hepatology. It is assumed, that these specialities at the outset have different concepts and setups for diagnosing and treatment of intercurrent infections.